Amanda C. Foks received her PhD in ‘Regulation of immune responses in atherosclerosis’ at the Leiden Academic Centre for Drug Research (LACDR), Leiden University, the Netherlands, in 2013. Following postdoctoral training in the laboratory of Prof.dr. Lichtman at Harvard Medical School/Brigham and Women’s Hospital in Boston, USA, she established her own research group focusing on adaptive and age-associated immunity in atherosclerosis at the Division of BioTherapeutics of the LACDR, Leiden University, in 2019. In 2023, Amanda Foks was appointed as Associate Professor. Her team focuses on gaining mechanistic insights into atherosclerosis development, identification of age-associated inflammatory biomarkers and the development of novel anti-inflammatory interventions to treat atherosclerotic CVD.